Paradise Papers leak: No violation by Fortis doctor, says IMA

Reports linked to the Paradise Papers have alleged that Dr Seth has prescribed stents of Biosensors International to his patients despite being a shareholder of the co

Dollar
Dollar
Veena Mani New Delhi
Last Updated : Nov 07 2017 | 2:27 AM IST
Indian Medical Association (IMA), a voluntary organisation for doctors, has come out in support of fellow doctor Ashok Seth, who’s been named in the latest Paradise Papers leak on big corporates and wealthy individuals moving money from and to 19 tax havens.

Reports suggest that Dr Seth, a cardiologist in Fortis Escorts, had shares in a Singapore-based stent company Biosensors International Group. 

K K Agarwal, IMA secretary, said the rules allow doctors to be part of any company. However, the doctor should not lose his sense of professional judgement, he added.

Fortis Healthcare said in an e-mail statement, “Dr Ashok Seth is an eminent cardiologist and a valuable member of Fortis organisation. We believe that he has always acted in the best interest of the patients and has practised in accordance with the law and commonly accepted medical guidelines. We do not see a conflict of interest or lack of ethics as he neither promoted the stents nor influenced any decision process regarding purchase of such stents.”

Reports linked to the Paradise Papers have alleged that Dr Seth has prescribed stents of Biosensors International to his patients despite being a shareholder of the company. Dr Seth had bought shares in Biosensors International which he had sold before the company listed in the Singapore bourses, as per reports.

In his defence, Seth had responded by saying that he did not use Biosensors’ devices when he was a shareholder in the company. 

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Next Story